Scale Confidently. Grow Enterprise Value

Expanding market share in healthcare is one of the fastest ways to increase enterprise value. It’s also one of the hardest.

Book a Market Expansion Review

Mid-market healthtech and pharmacy leaders face:

  • Long, multi-stakeholder sales cycles that slow momentum

  • Fragmented decision networks across providers, systems, and partners

  • Uneven credibility across regions that limits pricing power

  • Entrenched competitors with deeper relationships and stronger brand recognition

Too many companies scale reactively, relying on disconnected tactics and untested assumptions. The result is wasted time, diluted budgets, and stalled valuation.

At Legacy DNA, we help growth-stage healthtech and pharmacy companies expand strategically with clarity, speed, and measurable impact on enterprise value.

Start a market expansion review and get a clear plan to scale with confidence.

We build scalable market expansion frameworks that align commercial strategy, demand generation, and valuation growth.

We help you:

  • Prioritize expansion moves that create enterprise value: Identify the markets, segments, and partnerships that deliver the highest return on growth investment

  • Strengthen market leadership: Elevate your brand narrative and credibility across key stakeholders including health systems, strategic partners, investors, and acquirers

  • Accelerate commercial performance: Align go-to-market, sales, and channel strategies to drive revenue growth, margin expansion, and valuation gains

  • Connect growth to valuation outcomes: Measure expansion success through ROI, pricing power, and enterprise value impact

Ready to expand with clarity and confidence?

Build a Market Presence Buyers Cannot Ignore

Schedule your Market Expansion Review today.

Real-World Proof: BioPlus $2B Growth Story

When BioPlus Specialty Pharmacy partnered with Legacy DNA, they were respected but nearly invisible in a crowded specialty pharmacy market. Competitors were consolidating, PBM giants were tightening control, and buyers overlooked their value.

We clarified the story and built a repeatable growth engine that changed their trajectory:

  • Created the iconic Power of 2™ story: 2 Hour Patient Acceptance Guarantee™, 2 Day Ready to Ship™, 2 Click Refills™, a straightforward narrative customers remembered and buyers could not ignore

  • Enabled 13 consecutive quarters of growth by embedding as Fractional CMO and building a disciplined commercialization engine

  • Drove measurable outcomes:

    • Revenue grew $750M → $2B

    • Gross profit up 202% in three years

    • Dispenses scaled 78K → 325K in seven years (22.5% CAGR)

  • Positioned BioPlus for two premium exits, first to Nautic Partners/CarepathRx, then to Elevance Health

“We had something good. Legacy DNA made it better. And then some.” — Dr. Stephen Vogt, Founder and CEO, BioPlus Specialty Pharmacy

The Market Expansion & Valuation Acceleration Blueprint

In as little as 90 days, we clarify where to play, how to win, and how to prove value to investors and buyers. Then we stay engaged to ensure the plan turns into momentum, not just a deck. Work often begins in our Exit Readiness Sprint™.

Market Intelligence That Drives Smart Decisions

We combine qualitative and quantitative insight to create clarity and competitive advantage.

  • Competitive landscape and white space opportunity mapping: See how key players position and price, and identify where you can lead instead of just competing

  • Market sizing and segmentation: Quantify market potential, define high-value buyer segments, and prioritize regions for scalable growth

  • Revenue and valuation levers: Analyze external forces, growth drivers, and market signals that influence pricing power and exit outcomes

Customer Insights That Reduce Risk

Avoid costly missteps by understanding who truly drives adoption.

  • Buyer personas and adoption triggers: Identify who drives decisions and what moves them to action

  • Barriers-to-adoption analysis: Anticipate objections and design evidence-based strategies to overcome them

Commercial Scale & Valuation Framework

  • Market positioning strategy: Strengthen credibility and leadership across provider, partner, and investor audiences

  • Unified messaging framework: Align your story across commercial, clinical, and capital markets to increase visibility and trust

  • Commercial performance plan: Optimize go-to-market execution, channel strategy, and sales enablement to expand market share and drive valuation growth

Proof That Accelerates Traction and Valuation

Evidence packaging begins in our Premium Acquisition Sprint™ and expands through our Healthcare Growth Engine Partnership™.

  • Data and evidence packaging: Build investor-grade proof that validates commercial expansion and strengthens valuation

  • Early customer wins: Document initial success stories to establish credibility and market momentum

  • Growth dashboards: Track KPIs that keep leadership, boards, and investors confident

Map your path to market expansion and build negotiating power now.

Your Growth Partner for Scale and Enterprise Value

  • Deep healthcare focus: Exclusively focused on healthtech and pharmacy for over two decades, delivering proven growth and enterprise value.
    Proven, repeatable systems: Frameworks from market intelligence to valuation dashboards built on real expansion and acquisition success

  • Exit-driven growth: Every move planned with buyers and investors in mind to reduce risk and increase enterprise value

  • Hands-on partnership: We work alongside your team to turn strategy into market momentum

  • Leadership buyers trust: Founded by Dr. Roxie Mooney, a healthcare commercialization expert, and powered by a seasoned growth team with multiple premium exits

Talk With Our Healthcare Growth Experts Now

Frequently Asked Questions

  • We partner with mid-market healthcare and life science innovators spanning healthtech, medtech, pharmacy, AI, digital medicine, and consumer wellness. This includes sectors such as longevity, women’s health, precision medicine, mental and behavioral health, and specialty care. Our clients are scaling in the U.S. and preparing for growth, investment, or exit.

  • Legacy DNA is a human-first, AI-powered growth firm. We build commercialization systems that reduce risk, accelerate adoption, and drive valuation, not one-off campaigns.

  • You will have a market expansion roadmap in as little as 90 days and early momentum as soon as the plan activates.

  • No. We provide strategic clarity and execution coaching so your team can implement with confidence.

  • Every deliverable is built with the investor and acquirer lens to demonstrate traction, defensibility, and pricing power.

  • We specialize in course correction. We diagnose what went wrong, reframe the approach, and relaunch with a plan tied to valuation.

  • We do not replace legal or compliance teams. We ensure your commercialization plan accounts for the regulatory and economic environment so you can scale without costly missteps.

  • Yes. We partner with PE-backed healthtech and pharmacy leaders to accelerate value creation ahead of exit.

  • Absolutely. Many clients come to us after early growth stalls. We refine positioning, strengthen buyer alignment, and build systems to scale nationally and increase enterprise value.

  • Book a Market Expansion Review. We will assess goals, surface gaps, and design a clear plan to scale confidently.

Stronger Market Moves. Smarter Growth. Higher Valuation.

Expanding is not just about selling more. It is about proving your model at scale, earning buyer confidence, and increasing enterprise value.

With Legacy DNA, you will:

  • Turn market clarity into negotiating leverage

  • Translate commercial performance into defensible valuation gains

  • Build the narrative and assets that drive premium multiples at exit

Stop gambling your growth on guesswork. Partner with a proven healthcare growth team.

Schedule Your Market Expansion Review.

This small, independent specialty pharmacy wanted to dance with the giants, but first, they needed to find their rhythm. Armed with stronger branding, positioning, and thought leadership, they learned new routines. It wasn’t long before they could jump on the dance floor and hustle their way to explosive growth (968% in one decade), taking their pharmacy from millions to billions.

Embracing a paradigm shift from traditional marketing, this tech platform undertook a comprehensive overhaul. Using more strategic go-to-market processes, they ushered their specialty pharmacy innovations into the modern era. Today, they continue to lead the way with their pioneering reputation and forge a path towards a more transformative future.

Armed with firsthand insights and feedback from numerous patients, this physician had a uniquely clear vision of the market's requirements. The problem was that he was up against a saturated landscape commanded by well-established household brands with deep pockets and enduring customer loyalty. The challenge lay in carving a distinctive niche. Leveraging a dynamic and robust commercialization strategy along with a bold brand identity, his product managed to not only capture the spotlight but also secure coveted shelf space within prominent big-box retailers.

It’s easy to coast along when you’re making a profit in an industry that’s full of growth and opportunity. But this independent pharmacy buying group wanted to take it to the next level. With a robust strategic marketing plan and by leveraging modern tools, tactics, and best practices, they were able to drive rapid growth and transform into an online destination for independent pharmacy owners.

With a lean team and limited resources, this company harnessed a late-entrant advantage, crafting an ingenious brand strategy that utilized a SaaS model and AI to creatively exploit the gaps left by dominant market players. The result? They were not only able to compete against industry giants, they went on to absorb their top competitor in just two years, reshaping the market landscape.

In an industry barreling toward commoditization, this specialty pharmacy recognized the urgency of setting itself apart. Through a blend of enhanced, strategic branding and impactful messaging, they were able to secure their market position in the hearts and minds of patients and stakeholders, making them a desirable target for acquisition.

This specialty pharmacy built a strong name for itself in the HCV field - but struggled to stay visible in a saturated market. Leadership knew marketing resources were stretched thin, and they had no real strategic plan in place, but the market was experiencing massive growth. Capitalizing on that growth meant they needed a plan - a marketing plan. Two years later, with a strategic marketing plan and enhanced foundational assets in place, their net worth soared from $50 million to $500 million, making them an irresistible acquisition for the fifth-largest pharmacy in the United States.

This digital health startup set out to develop an early adoption strategy and a clear path to market. While developing the strategies that would help them avoid pitfalls, circumvent failure, and recognize opportunities, COVID hit. Armed with their newly acquired early adoption vision, they were able to confidently perform a powerful pandemic pivot to success.

As seen on